Delivery Order SPE2DB24D1006-SPE2DB24FCEPS

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $76K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $7,726.45 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. This award is not set aside. Amerisourcebergen is a major pharmaceutical distributor that holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $4,835.77 delivery order placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of December 2, 2022. The award is a firm fixed-price contract and was not designated with any set-aside...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,506.87 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a ceiling value of $105,258.11. The award is for the provision of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support the Defense Logistics Agency (DLA) Troop Support Medical program. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order with a ceiling value of $9,038.50, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies under a broader Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $38,371.31 firm fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of STELARA 90 MG/ML syringes, a specialty pharmaceutical product, with an ultimate completion date of August 9, 2024. This delivery order is not set aside and is part of the broader DLA Troop Support Medical contract, valued up to...
This federal contract award, valued at $41,477.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that was previously awarded to Amerisourcebergen by the DLA Troop Support Medical. The contract covers the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,591.92 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The award is not associated with a set-aside program. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,684.96 firm fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is a delivery order with a value of $32,773.74 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication, with an ultimate completion date of October 2, 2023. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB24FCEPS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $76,057.05 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. This award is not designated as a set-aside contract. Amerisourcebergen, through its Corporate Office Division, will deliver the requested pharmaceutical items to support federal healthcare programs and military treatment facilities nationwide with an ultimate completion date of September 27, 2024. The DLA is the primary funding agency for this contract, which is part of the agency's broader efforts to provide essential medical commodities to the U.S. armed forces and other government beneficiaries.

Generated 12/26/24, 9:26 AM